Bill Activity

Bill Enacted

This bill was enacted into law on 2021-04-23

Contributions

Individuals

There were no contributions to this bill.

You must be logged in to contribute

Main Subject: Health

Advancing Education on Biosimilars Act of 2021 This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.) The FDA may also maintain and operate a website to provide educational materials about biological products.

HR19-117, HR1873-117,

Library of Congress Actions

President
Apr. 23 2021	Became Public Law No: 117-8. Signed by President.
Apr. 20 2021	Presented to President.

BecameLaw
Apr. 23 2021	Became Public Law No: 117-8. Signed by President.

Floor
Apr. 14 2021	Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101).(text: CR H1754)
Mar. 03 2021	Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(text: CR S1021)

House floor actions Actions

Floor
Apr. 20 2021	Presented to President.
Apr. 14 2021	Motion to reconsider laid on the table Agreed to without objection. On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101). (text: CR H1754) Considered as unfinished business. (consideration: CR H1783-1784) At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed. DEBATE - The House proceeded with forty minutes of debate on S. 164. Considered under suspension of the rules. (consideration: CR H1754-1755) Mr. Pallone moved to suspend the rules and pass the bill.
Mar. 08 2021	Held at the desk. Received in the House.